GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tabula Rasa HealthCare Inc (NAS:TRHC) » Definitions » ROE %

Tabula Rasa HealthCare (Tabula Rasa HealthCare) ROE % : 0.00% (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Tabula Rasa HealthCare ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Tabula Rasa HealthCare's annualized net income for the quarter that ended in Jun. 2023 was $-39.4 Mil. Tabula Rasa HealthCare's average Total Stockholders Equity over the quarter that ended in Jun. 2023 was $-74.5 Mil. Therefore, Tabula Rasa HealthCare's annualized ROE % for the quarter that ended in Jun. 2023 was N/A%.

The historical rank and industry rank for Tabula Rasa HealthCare's ROE % or its related term are showing as below:

During the past 10 years, Tabula Rasa HealthCare's highest ROE % was 14.21%. The lowest was -70.50%. And the median was -40.54%.

TRHC's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.115
* Ranked among companies with meaningful ROE % only.

Tabula Rasa HealthCare ROE % Historical Data

The historical data trend for Tabula Rasa HealthCare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tabula Rasa HealthCare ROE % Chart

Tabula Rasa HealthCare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.96 -19.99 -45.73 -70.50 -

Tabula Rasa HealthCare Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,343.12 - - - -

Competitive Comparison of Tabula Rasa HealthCare's ROE %

For the Health Information Services subindustry, Tabula Rasa HealthCare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tabula Rasa HealthCare's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tabula Rasa HealthCare's ROE % distribution charts can be found below:

* The bar in red indicates where Tabula Rasa HealthCare's ROE % falls into.



Tabula Rasa HealthCare ROE % Calculation

Tabula Rasa HealthCare's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=-147.51/( (55.756+-57.031)/ 2 )
=-147.51/-0.6375
=N/A %

Tabula Rasa HealthCare's annualized ROE % for the quarter that ended in Jun. 2023 is calculated as

ROE %=Net Income (Q: Jun. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Jun. 2023 ))/ count )
=-39.404/( (-70.864+-78.079)/ 2 )
=-39.404/-74.4715
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2023) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Tabula Rasa HealthCare  (NAS:TRHC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-39.404/-74.4715
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-39.404 / 360.144)*(360.144 / 355.767)*(355.767 / -74.4715)
=Net Margin %*Asset Turnover*Equity Multiplier
=-10.94 %*1.0123*N/A
=ROA %*Equity Multiplier
=-11.07 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-39.404/-74.4715
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-39.404 / -38.44) * (-38.44 / -22.728) * (-22.728 / 360.144) * (360.144 / 355.767) * (355.767 / -74.4715)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0251 * 1.6913 * -6.31 % * 1.0123 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Tabula Rasa HealthCare ROE % Related Terms

Thank you for viewing the detailed overview of Tabula Rasa HealthCare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tabula Rasa HealthCare (Tabula Rasa HealthCare) Business Description

Traded in Other Exchanges
N/A
Address
228 Strawbridge Drive, Suite 100, Moorestown, NJ, USA, 08057
Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The cloud-based software solutions of the company help prescribers, pharmacists, and healthcare organizations in managing the medication-related needs of patients. The firm operates the business through two segments namely CareVention HealthCare and MedWise HealthCare.
Executives
Michael Anthony Bruno officer: CHIEF ACCOUNTING OFFICER 1504 PEAR TREE LANE, BENSALEM PA 19020
Derek C Schrier director, 10 percent owner C/O INDABA CAPITAL MANAGEMENT, LLC, ONE LETTERMAN DR., BLDING D, SUITE DM700, SAN FRANCISCO CA 94129
Indaba Capital Fund, L.p. director, 10 percent owner MAPLES CORPORATE SERVICES, 121 SOUTH CHURCH STREET, GRAND CAYMAN E9 KY1-1104
Indaba Capital Management, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Ic Gp, Llc director, 10 percent owner ONE LETTERMAN DRIVE,, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Rew Richard W. Ii officer: Chief Legal Officer, Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
Thomas Cancro officer: CHIEF FINANCIAL OFFICER C/O GFI GROUP INC., NEW YORK NY 10041
Michael J. Purcell director C/O PATRIOT NATIONAL, INC., 401 E. LAS OLAS BLVD., SUITE 1650, FORT LAUDERDALE FL 33301
Ronald Paul Mitchell director 110 W. KINZIE STREET, 5TH FL, CHICAGO IL 60654
Jonathan David Schwartz director 430 EAST 29TH STREET, SUITE 1040, NEW YORK NY 10016
Dennis Helling director 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Michael Greenhalgh officer: Chief Operating Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Gordon Tunstall director
Andrea Carolan Speers officer: Chief Accounting Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Brian W Adams officer: Chief Financial Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057